Target Healthcare REIT reports 2.5% rise in NTA

Published 04/11/2025, 08:32
© Reuters.

Investing.com -- Target Healthcare REIT (LON:THRL) reported a 2.5% increase in EPRA NTA to 117.7p in its latest trading update.

The company exchanged on the previously announced £85.9 million disposal of nine care homes at an 11.6% premium and 5.2% implied net initial yield (NIY). The EPRA "topped-up" NIY for the portfolio stands at 6.24%.

Adjusted EPRA earnings per share rose to 1.71p, supporting a dividend of 1.508p, which represents a 2.5% increase.

The portfolio value increased by 2% in the quarter to £948.3 million, comprising 93 homes with 98% rent collection and a weighted average unexpired lease term of 25.7 years. Contractual rent grew 1.8% from inflation-linked reviews and a completed development.

Net loan-to-value ratio fell to 21.4%, with £138 million capital available for reinvestment. The company’s debt refinancing extended the average term to 5.9 years, with £200 million fixed at 3.89% until 2030.

Re-tenanting efforts improved both rent recovery and valuation for the real estate investment trust.

Kenneth MacKenzie, CEO of Target Fund Managers, said: "The Group’s strong results in the quarter demonstrate the attractiveness of our modern, purpose-built care home portfolio and the value delivered through the active management model."

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.